Vantage logo

On the hunt for a Covid-19 vaccine

As Cepi asks for $2bn to fund development of a vaccine against coronavirus and Moderna moves into the clinic, Vantage takes a look at previous pandemic development costs.

Vantage logo

Big-caps join the coronavirus scramble

It is no longer just small biotechs that are taking aim at coronavirus: Gilead Sciences and Glaxosmithkline are getting involved too, albeit via different routes.

Vantage logo

Medtech VC and the billion-dollar era

The first one-shot billion-dollar venture investment round in the medical technology sector has gone to Verily as computing bleeds into medicine.